MLXIPL and metabolic dysfunction-associated steatotic liver disease: Moreover, the liver-specific ChREBP-KO exhibits a 23% reduction of fatty acid oxidation in liver, where carbohydrates were predominantly utilized as substrate, further supporting our study’s finding that mice fed with HFD developed NAFLD [23].